Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. 10x Genomics Inc’s current trading price is -68.62% away from its 52-week high, while its distance from the 52-week low is 30.75%. The stock’s price range during this period has varied between $6.78 and $28.25. The company, active in the Healthcare sector, saw a trading volume of around 2.33 million for the day, considerably lower average daily volume of 3.62 million observed over the last three months.
10x Genomics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $28.25 on 05/14/24, and the lowest price during the same period was recorded at $6.78 on 04/07/25.
How Financial Performance Impacts Market Capitalization
10x Genomics Inc (TXG) has experienced a quarterly decline of -37.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.09B and boasts a workforce of 1306 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.57, with a change in price of -6.05. Similarly, 10x Genomics Inc recorded 2,982,597 in trading volume during the last 100 days, posting a change of -40.50%.
How TXG’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TXG stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.
TXG Stock Stochastic Average
As of today, the raw stochastic average of 10x Genomics Inc over the past 50 days is 42.22%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 57.72%. Additionally, the Stochastic %K and %D values for the company were 71.25% and 72.21%, respectively, over the past 20 days.
TXG Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -38.27%.However, over the last six months, we can see a stronger performance of -48.88%. Over the last 30 days, the price of TXG has fallen by 2.25%. And in the last five days, it has surged by 5.16%.
